Good places to research for healthcare groups?

Title, applying because I genuinely am interested in pharma/healthcare/medical innovation. I know some stuff here and there, but less so about specific companies. People working in these groups, are there any resources/new sources/etc that you like to read to stay up to date?

3 Comments
 

Based on the most helpful WSO content, here are some excellent resources to research healthcare groups and stay updated on the industry:

  1. News and Reports:

    • FiercePharma
    • FierceBiotech
    • Fierce MedTech
    • BioSpace
    • WSJ Health
    • Medscape
    • Axios Vitals
    • Bain's Global Healthcare Private Equity and Corporate M&A reports
    • Paul Keckley's weekly report (great for political analysis and government insights)
  2. Medical Device Industry:

    • MassDevice
    • Medical Device Manufacturers Association (MDMA)
  3. Books:

    • The Pharmagellan Guide to Biotech Forecasting and Valuation
    • Biotechnology Valuation by Karl Kleegan (focus on Chapters 3 and 4 for drug development and disease modeling)
  4. Additional Tips:

    • Follow Twitter accounts of key organizations like MDMA for quick updates.
    • Evaluate Pharma (paid source) is highly detailed but not necessary if you're just starting out.

These resources will help you understand the market, company valuations, and the impact of clinical trials and regulations on the industry.

Sources: Divergence in the Drug Businesses: Pharmaceuticals and Biotechnology, Healthcare IBD - Summary & Resources, Healthcare Overview... Part 1?, Healthcare IBD - Summary & Resources, Healthcare Overview... Part 1?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Suscipit et voluptatem rem vel. Exercitationem omnis quis possimus perspiciatis est perferendis molestiae fugit. Qui eveniet nisi quis sunt ut voluptas perferendis.

Unde dolorem sint cumque possimus. In dolores molestiae est aut modi atque dolorum. Sit in esse cumque. Eos est eum consequuntur impedit in.

Labore asperiores et voluptatem laborum. Reprehenderit fuga id porro rem in. Quibusdam dolores et deleniti explicabo porro culpa omnis omnis. Sunt eos esse rem odio. Earum laudantium nam fugit quia dicta saepe odit unde. Nihil voluptatem nihil consectetur vel sed aliquid consectetur. Perferendis nihil mollitia est quia et fugiat dolores id.

Explicabo facere expedita et aperiam laboriosam tempore doloribus. Est facere cum modi voluptatem. Soluta sit velit dignissimos dignissimos. Dolorem nobis voluptas et laudantium rem.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.9%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 03 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (53) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (15) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”